June 4, 2025
Authored and Edited by Daniel F. Klodowski; Umber Aggarwal; Deena Kablaoui Lanier; Nicholas A. Eitsert; A. Sasha Hoyt; Elliot C. Cook
PTAB trial outcomes in March and April generally tracked long-term statistical trends. In March, the PTAB cancelled 375 (72.25%) instituted claims across 34 IPR and PGR Final Written Decisions, including decisions issued following remand from the Federal Circuit. After review, 138 (26.59%) instituted claims survived, and patent owners conceded 6 (1.16%) instituted claims through motions to amend or disclaimer. For comparison, the cumulative average cancellation rate of instituted claims in IPR, CBM, and PGR Final Written Decisions is about 74%.

On a per-case basis, no instituted or substitute claims survived in 22 (64.71%) decisions, all instituted claims survived in 8 (23.53%) decisions, and 4 (11.76%) decisions had a mixed outcome in which at least one instituted or substitute claim survived and at least one instituted claim was cancelled.

In April, a relatively difficult month for patent owners, the PTAB cancelled 237 (84.64%) instituted claims across 22 IPR and PGR Final Written Decisions. In those decisions, 43 (15.36%) instituted claims survived, and patent owners did not concede any instituted claims through motions to amend or disclaimer.

On a per-case basis, no instituted or substitute claims survived in 16 (72.73%) decisions, all instituted claims survived in 3 (13.64%) decisions, and a mixed outcome occurred in 3 (13.64%) decisions in April.

Turning to motions to amend that were addressed on the merits in a Final Written Decision, the PTAB has cumulatively granted 677 (15.54%) proposed substitute claims while denying 3,679 (84.46%) proposed substitute claims through April 30, 2025.

Patentees have had slightly more success with motions to amend in PGRs. Through April 30, the PTAB granted 69 (20.60%) proposed substitute claims in PGR motions to amend while denying 266 (79.40%) proposed substitute claims.

The overall cumulative instituted claim survival rate in IPRs, CBMs, and PGRs through April 30, 2025, broken down by technology center, is as follows:

The cumulative number of Final Written Decisions through April 30, 2025, separated by technology center, is as follows:

Additional cumulative statistics on the Board’s IPR, CBM, and PGR decisions, updated through April 30, 2025, are available here on the At the PTAB blog.
Various other PTAB metrics collected and generated by Finnegan are reserved for the use of Finnegan and its clients. Stay tuned to the At the PTAB Blog for the latest updates, analysis, and statistics on all aspects of PTAB practice. Subscribe to receive notifications of new posts via email.
Copyright © 2025 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP.
DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.
At the PTAB Blog
Discretion All the Way Down: USPTO Uses a Discretionary IPR Denial to Justify a
§ 325(d) EPR Denial
May 28, 2026
At the PTAB Blog
IPR and PGR Statistics for Final Written Decisions Issued in March and April 2026
May 26, 2026
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.